Validation of a Methodology Using Isometric Dynamometer for Ankle STrength Assessment to Quantify LDH-induced Paresis (VAST-LDH)
Validation of a Methodology Using Isometric Dynamometer for Ankle Strength Assessment to Quantify LDH-induced Paresis
Lumbar disc herniation (LDH) is a common condition that may cause lower limb motor weakness (paresis), particularly affecting ankle dorsiflexion and plantarflexion. Although motor deficits are clinically important and may influence treatment decisions, objective and standardized methods for quantifying the severity of paresis are lacking. Current clinical assessment mainly relies on manual muscle testing, which is subjective and has limited sensitivity, while isokinetic dynamometry, the reference standard for muscle strength assessment, is expensive and impractical for routine clinical use.
This prospective validation study aims to evaluate a clinically feasible isometric ankle strength measurement method based on a handheld dynamometer fixed with an external strap to eliminate examiner-dependent resistance. The study will be conducted in two sequential phases. First, validity and reliability of the method will be established in healthy adult volunteers by comparing measurements with those obtained using an isokinetic dynamometer. Second, the method will be applied in patients with LDH-induced lower limb paresis to determine its performance across a broader range of muscle strength values and its clinical applicability.
Outcome measures include maximal isometric ankle dorsiflexion and plantarflexion force, time to peak force, manual muscle testing (Medical Research Council scale), patient-reported weakness using a Numeric Rating Scale, Lower Extremity Functional Scale (LEFS) scores, and functional ankle strength tests. Validity will be assessed using correlation analyses and Bland-Altman agreement analysis, while intra- and inter-rater reliability will be evaluated using intraclass correlation coefficients, coefficient of variation, standard error of measurement, and minimum detectable change.
The study seeks to establish a reliable, valid, and clinically practical method for objective assessment of ankle muscle strength in patients with LDH-induced paresis. Such a method could improve clinical evaluation, enable objective monitoring of recovery, facilitate future clinical research, and support treatment decision-making.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
Lumbar disc herniation (LDH) is one of the most common causes of lumbar radiculopathy and may result in lower limb motor weakness due to nerve root compression. While radicular pain often improves with conservative treatment, motor deficits may persist, recover slowly, or require surgical intervention. Despite the clinical importance of paresis, objective quantification of muscle weakness remains challenging because no standardized, practical, and validated measurement method is routinely available for clinical use.
Current clinical assessment primarily relies on manual muscle testing (MMT), which uses an ordinal grading system and is inherently subjective. MMT is limited by examiner experience, strength, and the inability to detect small but clinically meaningful changes in muscle function. Isokinetic dynamometry is widely regarded as the reference standard for objective muscle strength assessment because of its high accuracy and reproducibility. However, the equipment is expensive, non-portable, requires specialized training, and is therefore unsuitable for routine outpatient assessment or repeated follow-up measurements.
This study aims to validate a portable isometric ankle strength measurement method using a handheld dynamometer secured with an external fixation strap, minimizing examiner-related variability. The ultimate goal is to develop a clinically feasible method capable of objectively quantifying ankle dorsiflexion and plantarflexion strength in patients with LDH-induced paresis.
The study is designed as a prospective observational validation study conducted at Helsinki University Hospital. It consists of two consecutive phases.
During the first phase, healthy adult volunteers will undergo repeated ankle strength measurements using both the investigational handheld dynamometer method and an isokinetic dynamometer. This phase will establish criterion validity by comparing the handheld measurements with the reference standard. In addition, intra-rater and inter-rater reliability of the handheld method will be assessed through repeated measurements performed by different examiners.
If adequate validity and reliability are demonstrated, the second phase will recruit patients diagnosed with lumbar disc herniation presenting with clinically verified lower limb paresis. The objective of this phase is to evaluate whether the measurement method performs across the full spectrum of muscle weakness encountered in clinical practice and to determine its clinical relevance.
Primary measurements include maximal isometric ankle dorsiflexion and plantarflexion force and time to peak force. Secondary assessments include manual muscle testing according to the Medical Research Council grading system, patient-reported weakness using an 11-point Numeric Rating Scale, Lower Extremity Functional Scale (LEFS), and functional performance tests consisting of repeated toe raises and heel raises.
Criterion validity will be evaluated by comparing handheld dynamometer measurements with isokinetic dynamometer measurements using Pearson or Spearman correlation coefficients, linear regression analyses, and Bland-Altman plots to assess agreement and systematic bias. Construct validity will be examined by correlating objective strength measurements with patient-reported weakness, LEFS scores, and functional performance tests. Reliability will be assessed using intraclass correlation coefficients for both intra-rater and inter-rater agreement, together with coefficient of variation, standard error of measurement, and minimum detectable change.
Approximately 35 healthy volunteers and 35 patients with LDH-induced paresis will be recruited to allow for participant dropout while maintaining adequate statistical power based on previous validation studies.
The study involves no therapeutic intervention and poses minimal risk. Participants will undergo standardized muscle strength testing and complete patient-reported outcome measures. Any discomfort, such as muscle cramps or transient fatigue during testing, will be documented. Participants demonstrating clinically significant deterioration in muscle strength during the study will be referred for further clinical evaluation according to standard practice.
By establishing a valid, reliable, and practical method for objective ankle strength assessment, this study aims to improve the evaluation and longitudinal monitoring of patients with LDH-induced paresis. The validated methodology may facilitate future clinical trials, improve outcome assessment, enable earlier recognition of neurological recovery or deterioration, and support evidence-based treatment decisions in patients with lumbar disc herniation.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Uusimaa
-
Helsinki, Uusimaa, Finland, 00290
- Helsinki University Central Hospital
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Beskrivelse
First phase
Inclusion Criteria:
- Aged 18-65 years old
- No pathology affecting ankle dorsiflexion or plantarflexion strength
Exclusion Criteria:
- Pathology affecting ankle dorsiflexion or plantarflexion strength
Second phase
Inclusion Criteria:
- Aged 18-65 years old
- LDH-induced muscle weakness of ankle dorsiflexion or plantarflexion
Exclusion Criteria:
- No muscle weakness induced by herniated lumbar disc
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Andet: Study participant
Person participating in validity and reliability assessment
|
Ankle dorsiflexion and plantarflexion isometric maximal voluntary contraction strength test
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Criterion validity of the isometric handheld dynamometer
Tidsramme: At baseline (first measurement session; Day 0)
|
Agreement between the investigational isometric handheld dynamometer (HHD) measurement method and the reference standard isokinetic dynamometer (IKD) for maximal ankle dorsiflexion and plantarflexion strength.
|
At baseline (first measurement session; Day 0)
|
|
Construct validity of the handheld dynamometer
Tidsramme: At baseline (first measurement session; Day 0)
|
Correlation of HHD measurements with patient-reported weakness (Numerical Rating Scale), Lower Extremity Functionality Scale questionnaire, manual muscle testing (Medical Research Council grade) and functional ankle performance tests.
|
At baseline (first measurement session; Day 0)
|
|
Intra-rater reliability of the handheld dynamometer
Tidsramme: At baseline (Day 0) and at the second measurement session, within 7 days after baseline
|
Test-retest reliability of ankle dorsiflexion and plantarflexion strength measurements obtained by the same examiner.
|
At baseline (Day 0) and at the second measurement session, within 7 days after baseline
|
|
Inter-rater reliability of the handheld dynamometer
Tidsramme: At the second measurement session, within 7 days after baseline
|
Agreement between measurements performed by different examiners
|
At the second measurement session, within 7 days after baseline
|
Andre resultatmål
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Maximal isometric ankle dorsiflexion strength
Tidsramme: At baseline (first measurement session; Day 0)
|
Maximum voluntary isometric dorsiflexion force measured using the handheld dynamometer
|
At baseline (first measurement session; Day 0)
|
|
Maximal isometric ankle plantarflexion strength
Tidsramme: At baseline (first measurement session; Day 0)
|
Maximum voluntary isometric plantarflexion force measured using the handheld dynamometer.
|
At baseline (first measurement session; Day 0)
|
|
Time to peak force
Tidsramme: At baseline (first measurement session; Day 0)
|
Time required to reach maximal voluntary isometric force during dorsiflexion and plantarflexion.
|
At baseline (first measurement session; Day 0)
|
|
Manual Muscle Testing (Medical Research Council scale)
Tidsramme: At baseline (first measurement session; Day 0)
|
Ankle muscle strength (plantarflexion and dorsiflexion) assessed using the Medical Research Council (MRC) 0-5 manual muscle testing scale (0 = no muscle contraction, 5 = normal strength)
|
At baseline (first measurement session; Day 0)
|
|
Participant-reported lower limb weakness (Numeric Rating Scale)
Tidsramme: At baseline (first measurement session; Day 0)
|
Self-reported severity of lower limb weakness measured using an 11-point Numeric Rating Scale (0 = no weakness, 10 = worst imaginable weakness).
|
At baseline (first measurement session; Day 0)
|
|
Participant reported function (Lower Extremity Functional Scale, LEFS)
Tidsramme: At baseline (first measurement session; Day 0)
|
Lower extremity function assessed using the Lower Extremity Functional Scale (score range 0-80, higher scores indicate better function).
|
At baseline (first measurement session; Day 0)
|
|
Functional ankle performance testing (heel raises, toe raises)
Tidsramme: At baseline (first measurement session; Day 0)
|
Functional ankle performance assessed by the maximum number of heel raises (plantarflexion) and toe raises (dorsiflexion).
|
At baseline (first measurement session; Day 0)
|
|
Participant-reported discomfort during measurements
Tidsramme: From baseline (Day 0) through completion of the second measurement session, up to 7 days after baseline
|
Occurrence of adverse symptoms during testing, including but not limited to muscle cramps, discomfort, or pain.
|
From baseline (Day 0) through completion of the second measurement session, up to 7 days after baseline
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- HUS/418/2026
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
IPD-delingstidsramme
IPD-delingsadgangskriterier
Researchers who provide a methodologically sound research proposal.
Data will be available upon reasonable request to the principal investigator, subject to institutional approval, applicable legislation, and a data sharing agreement.
IPD-deling Understøttende informationstype
- STUDY_PROTOCOL
- SAP
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .